Question 1

What is the catalog number for Dipalmitin (HSA)?

Accepted Answer

The catalog number for Dipalmitin (HSA) is abx165708.

Question 2

What sizes are available for Dipalmitin (HSA)?

Accepted Answer

Dipalmitin (HSA) is available in the following size(s): 100 µg, 200 µg, 500 µg, 1 mg, 5 mg.

Question 3

How many pack sizes does Dipalmitin (HSA) come in?

Accepted Answer

Dipalmitin (HSA) is available in 5 different pack sizes.

Question 4

Is Dipalmitin (HSA) in stock?

Accepted Answer

Dipalmitin (HSA) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Does this cell line or biologic require a Material Transfer Agreement (MTA)?

Accepted Answer

Some products, including certain cell lines, plasmids, and tissue cultures, are subject to intellectual property terms and may require an MTA before we can ship. We’ll inform you in advance if this product requires one, and additional handling fees may apply.

Question 6

What should I do if I need to report a performance issue with a specific lot of this product?

Accepted Answer

Provide the catalogue number, product name, lot number, and your experimental results to our technical support team. They’ll investigate and, if needed, escalate to the manufacturer, provided the product was used before expiry and stored correctly.

Question 7

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Dipalmitin (HSA)

Product Specifications

Conjugation

Applications

Notes

Tested Applications

Host or Source

Available Sizes

Frequently Asked Questions

Explore Other Products

SHISA6 Antibody

GM-CSF, Human

GM-CSF, Human

5430419D17Rik (NM_175166) Mouse Tagged ORF Clone

RAI3/GPRC5A Rabbit Polyclonal Antibody (APC)

NEUROG3 (Neurogenin-3, NGN-3, Class A Basic Helix-loop-helix Protein 7, bHLHa7, Protein Atonal Homolog 5, ATOH5, BHLHA7, NGN3, Math4B) (MaxLight 405) discontinued